Report ID: SQMIG35A2403
Report ID:
SQMIG35A2403 |
Region:
Global |
Published Date: October, 2024
Pages:
157
|
Tables:
88 |
Figures:
76
North America dominated the continuous renal replacement therapy (CRRT) market with the highest revenue share of 35.6% in 2021. The region's market growth is driven by the increasing prevalence of the geriatric population and the rising incidence of kidney disorders. Unhealthy lifestyles and dietary habits, such as sedentary lifestyles and poor eating habits, contribute to the growing incidence of lifestyle-related diseases like kidney dysfunction, hypertension, and diabetes. In the United States, for example, millions of adults are estimated to have chronic kidney disease (CKD), creating a significant demand for CRRT. These factors contribute to the growth of the CRRT market in North America.
In the Asia Pacific region, the market for continuous renal replacement therapy is projected to experience a high compound annual during the forecast period. The region's growth is fueled by significant unmet medical needs related to diseases like diabetes, hypertension, and chronic kidney disease. The healthcare expenditure in the region is continually improving, enabling better access to CRRT and other medical treatments. China has emerged as an attractive market for medical devices. The Chinese government has implemented measures to support the medical manufacturing industry, such as reducing the Value Added Tax (VAT) for medical manufacturing companies
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35A2403